OP0289 Treat-To-Target in Early Rheumatoid Arthritis: Association Between Sustained Remission and Joint Damage

doi 10.1136/annrheumdis-2017-eular.2366
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

Patient’s Perspective of Sustained Remission in Rheumatoid Arthritis

BMC Musculoskeletal Disorders
RheumatologyOrthopedicsSports Medicine
2017English

Remission Is the Mission : Effects of the Implementation of Treat-To-Target in Early Rheumatioid Arthritis

English

OP0226 Sustained Effectiveness of Methotrexate With Step-Down Glucocorticoid Remission Induction (Cobra Slim) for Early Rheumatoid Arthritis in a Treat-To- Target Setting: 2-Year Results of the Carera Trial

2017English

THU0085 Time to Remission and the Achievement of Sustained Remission in Patients With Early Rheumatoid Arthritis: Site Variation Analysis in Therapeutic Strategy From the Canadian Early Arthritis Cohort (CATCH)

2017English

Association Between Gold Induced Skin Rash and Remission in Patients With Rheumatoid Arthritis.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1990English

Adalimumab Discontinuation in Patients With Rheumatoid Arthritis After Achieving Sustained Remission

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2018English

Treat-To-Target and Treat-To-Budget in Rheumatoid Arthritis: Measuring the Value of Individual Therapeutic Interventions

Rheumatology and Therapy
2019English

Treat-To-Target Concept Implementation for Evaluating Rheumatoid Arthritis Patients in Daily Practice

European Journal of Rheumatology
2019English

Rheumatoid Arthritis Treatment: The Earlier the Better to Prevent Joint Damage

RMD Open
RheumatologyAllergyImmunology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy